Clinical Trial Update: Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated the stromal response to nab-paclitaxel in combination with gemcitabine for pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)

Snippet

Sponsor: Grupo Hospital de Madrid | Conditions: Pancreatic Cancer | NA | Status: COMPLETED